Klinische relevantie van incidentele prostaatlaesies op een FDG-PET/CT-scan: Dienen patiënten verder geëvalueerd te worden?

Translated title of the contribution: Clinical relevance of incidental prostatic lesions on FDG-PET/CT Scan: Should patients receive further evaluation?

Daan J. Reesink, Elisabeth E. Fransen van de Putte, Erik Vegt, Jeroen de Jong, Erik van Werkhoven, Laura S. Mertens, Axel Bex, Henk G. van der Poel, Bas W G van Rhijn, Simon Horenblas, Richard P. Meijer*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The purpose of this study was to determine the clinical relevance of incidental prostatic uptake (IPU) on FDG-PET/CT. We analyzed 108 male bladder cancer patients who underwent FDG-PET/CT imaging, and subsequently a cystoprostatectomy, from 2009–2014. IPU had a poor diagnostic accuracy for detecting prostate cancer. Classification of IPU as ‘suspect’ or ‘non-suspect’ by nuclear medicine physician did not improve diagnostic results. Physicians should therefore be cautious to apply invasive diagnostic methods to detect prostate cancer in case of IPU on FDG-PET/CT.

Translated title of the contributionClinical relevance of incidental prostatic lesions on FDG-PET/CT Scan: Should patients receive further evaluation?
Original languageDutch
Pages (from-to)80-87
Number of pages8
JournalTijdschrift voor Urologie
Volume6
Issue number5
DOIs
Publication statusPublished - 1 Aug 2016

Keywords

  • 18FDG
  • computed tomography (CT)
  • fluorodeoxyglucose F18
  • positron emission tomography (PET)
  • prostate cancer

Fingerprint

Dive into the research topics of 'Clinical relevance of incidental prostatic lesions on FDG-PET/CT Scan: Should patients receive further evaluation?'. Together they form a unique fingerprint.

Cite this